Literature DB >> 26576077

Hepatic immune tolerance induced by hepatic stellate cells.

Ching-Chuan Hsieh1, Chien-Hui Hung1, Lina Lu1, Shiguang Qian1.   

Abstract

The liver, which is a metabolic organ, plays a pivotal role in tolerance induction. Hepatic stellate cells (HpSCs), which are unique non-parenchymal cells, exert potent immunoregulatory activity during cotransplantation with allogeneic islets effectively protecting the islet allografts from rejection. Multiple mechanisms participate in the immune tolerance induced by HpSCs, including the marked expansion of myeloid-derived suppressor cells (MDSCs), attenuation of effector T cell functions and augmentation of regulatory T cells. HpSC conditioned MDSC-based immunotherapy has been conducted in mice with autoimmune disease and the results show that this technique may be promising. This article demonstrates how HpSCs orchestrate both innate immunity and adaptive immunity to build a negative network that leads to immune tolerance.

Entities:  

Keywords:  Hepatic stellate cells; Hepatic tolerance; Immunotherapy; Myeloid-derived suppressor cells

Mesh:

Substances:

Year:  2015        PMID: 26576077      PMCID: PMC4641110          DOI: 10.3748/wjg.v21.i42.11887

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  38 in total

1.  Prominent regulatory but weak antigen-presenting cell function of hepatic stellate cells.

Authors:  Frank A Schildberg; Christian Kurts; Percy A Knolle
Journal:  Hepatology       Date:  2011-09-02       Impact factor: 17.425

2.  TGF-β-dependent induction of CD4⁺CD25⁺Foxp3⁺ Tregs by liver sinusoidal endothelial cells.

Authors:  Antonella Carambia; Barbara Freund; Dorothee Schwinge; Markus Heine; Alena Laschtowitz; Samuel Huber; David C Wraith; Thomas Korn; Christoph Schramm; Ansgar W Lohse; Joerg Heeren; Johannes Herkel
Journal:  J Hepatol       Date:  2014-05-02       Impact factor: 25.083

3.  Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of t-cell function in advanced cancer patients.

Authors:  J Schmielau; O J Finn
Journal:  Cancer Res       Date:  2001-06-15       Impact factor: 12.701

4.  Induction of immunological tolerance by porcine liver allografts.

Authors:  R Y Calne; R A Sells; J R Pena; D R Davis; P R Millard; B M Herbertson; R M Binns; D A Davies
Journal:  Nature       Date:  1969-08-02       Impact factor: 49.962

Review 5.  Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies.

Authors:  S L Friedman
Journal:  N Engl J Med       Date:  1993-06-24       Impact factor: 91.245

6.  Fully allogeneic liver grafting in rats induces a state of systemic nonreactivity to donor transplantation antigens.

Authors:  N Kamada; G Brons; H S Davies
Journal:  Transplantation       Date:  1980-05       Impact factor: 4.939

7.  The lipocytes in normal human liver. A quantitative study.

Authors:  M P Giampieri; A M Jezequel; F Orlandi
Journal:  Digestion       Date:  1981       Impact factor: 3.216

8.  Hepatic Stellate Cells Improve Engraftment of Human Primary Hepatocytes: A Preclinical Transplantation Study in an Animal Model.

Authors:  Ange-Clarisse Dusabineza; Mustapha Najimi; Noémi van Hul; Vanessa Legry; Dung Ngoc Khuu; Leo A van Grunsven; Etienne Sokal; Isabelle A Leclercq
Journal:  Cell Transplant       Date:  2015-02-20       Impact factor: 4.064

9.  Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer.

Authors:  B Almand; J I Clark; E Nikitina; J van Beynen; N R English; S C Knight; D P Carbone; D I Gabrilovich
Journal:  J Immunol       Date:  2001-01-01       Impact factor: 5.422

10.  Hepatic stellate cell-conditioned myeloid cells provide a novel therapy for prevention of factor VIII antibody formation in mice.

Authors:  Sumantha Bhatt; Gong-Qing Shen; Yan Li; Shiguang Qian; Margaret V Ragni; Lina Lu
Journal:  Exp Hematol       Date:  2014-12-19       Impact factor: 3.084

View more
  11 in total

Review 1.  Why some organ allografts are tolerated better than others: new insights for an old question.

Authors:  Travis D Hull; Gilles Benichou; Joren C Madsen
Journal:  Curr Opin Organ Transplant       Date:  2019-02       Impact factor: 2.640

2.  Evodiamine ameliorates liver fibrosis in rats via TGF-β1/Smad signaling pathway.

Authors:  Dongmei Yang; Li Li; Shanjun Qian; Lixin Liu
Journal:  J Nat Med       Date:  2017-09-21       Impact factor: 2.343

Review 3.  Hepatic Stellate Cell: A Double-Edged Sword in the Liver.

Authors:  Nianan Luo; Jiangbin Li; Yu Wei; Jianguo Lu; Rui Dong
Journal:  Physiol Res       Date:  2021-10-30       Impact factor: 1.881

Review 4.  Combination of molecularly targeted therapies and immune checkpoint inhibitors in the new era of unresectable hepatocellular carcinoma treatment.

Authors:  Ze-Long Liu; Jing-Hua Liu; Daniel Staiculescu; Jiang Chen
Journal:  Ther Adv Med Oncol       Date:  2021-05-24       Impact factor: 8.168

5.  Levels of hepatic Th17 cells and regulatory T cells upregulated by hepatic stellate cells in advanced HBV-related liver fibrosis.

Authors:  Xiaoyan Li; Yujie Su; Xuefeng Hua; Chan Xie; Jing Liu; Yuehua Huang; Liang Zhou; Min Zhang; Xu Li; Zhiliang Gao
Journal:  J Transl Med       Date:  2017-04-11       Impact factor: 5.531

Review 6.  The Many Roles of Cell Adhesion Molecules in Hepatic Fibrosis.

Authors:  Edith Hintermann; Urs Christen
Journal:  Cells       Date:  2019-11-24       Impact factor: 6.600

7.  Fibrinogen-like protein 2 promotes the accumulation of myeloid-derived suppressor cells in the hepatocellular carcinoma tumor microenvironment.

Authors:  Bo-Qian Liu; Zhi-Ye Bao; Jia-Yi Zhu; Hao Liu
Journal:  Oncol Lett       Date:  2020-11-17       Impact factor: 2.967

8.  Mesenchymal stem cells inhibit T cell activation by releasing TGF-β1 from TGF-β1/GARP complex.

Authors:  Jian Niu; Wang Yue; Zhu Le-Le; Liu Bin; Xin Hu
Journal:  Oncotarget       Date:  2017-10-06

Review 9.  A Rising Star in Pancreatic Diseases: Pancreatic Stellate Cells.

Authors:  Ran Xue; Kai Jia; Jianxin Wang; Lixin Yang; Yanbin Wang; Lingyun Gao; Jianyu Hao
Journal:  Front Physiol       Date:  2018-06-18       Impact factor: 4.566

10.  Activated Hepatic Stellate Cells (HSCs) Exert Immunosuppressive Effects in Hepatocellular Carcinoma by Producing Complement C3.

Authors:  Yaping Xu; Yihao Huang; Wanqiong Xu; Xiaohui Zheng; Xue Yi; Liyue Huang; Yuxiao Wang; Kangni Wu
Journal:  Onco Targets Ther       Date:  2020-02-18       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.